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lished a Plague Surveillance Unit in
District Shimla of Himachal Pradesh
in 2002 (1).
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To the Editor: Tularemia is a
zoonosis caused by Francisella
tularensis. Recently, tularemia has
emerged in new locations, popula-
tions, and settings (1). After an out-
break in Spain in 1997 (2), it was
expected that the disease would
spread toward Portugal, a country
with an extended area that borders the
affected areas.
To evaluate the situation, a sur-
veillance project, including a seroepi-
demiologic study in human popula-
tions and detection of the nucleic acid
of F. tularensis in biologic samples,
was initiated. The district of
Bragança, in northern Portugal, was
selected as study area for its vicinity
with tularemia-endemic areas of
Spain and because Dermacentor retic-
ulatus and  Ixodes ricinus are well
documented there (3).
Biologic samples were collected
from 74 persons living in the study
region whose activities represented an
increased risk for contact with ticks
and wild mammals. Serum samples
were available from 48 and were ana-
lyzed with the microagglutination test
(4). From the other 26 persons, blood
samples were collected and frozen.
Because of hemolization these sam-
ples were only subjected to PCR.
DNA was extracted by using the
QIAamp blood kit (QIAGEN GmbH,
Hilden, Germany).
A total of 110 ticks were collect-
ed from vegetation by using the flag-
ging method (n = 5) or from verte-
brate hosts (n = 105) and were identi-
fied at the species level and processed
individually (5). Of these ticks, 79
were D. reticulatus, 1 I. ricinus, 15 D.
marginatus, 11  Rhipicephalus san-
guineus, and 4 Hyalomma margina-
tum.
A fragment of the gene encoding
the 17-kDa lipoprotein (Tul4) of F.
tularensis was amplified, as described
previously (6). Resulting products
were subjected to electrophoresis on
0.8% low-melt agarose gels (Roche
Diagnostics GmbH, Mannheim,
Germany), and the bands were puri-
fied by using the QIAquick gel extrac-
tion kit (QIAGEN GmbH) and
sequenced with the BigDye
Terminator Cycle Sequencing kit
(Applied Biosystems, Foster City,
CA, USA) on an ABI 377 DNA
sequencer. The sequences were
aligned with other sequences from
databases by using ClustalX (7).
Pairwise distance matrices were
determined by the Kimura 2-parame-
ter method, with MEGA3 software.
Phylogenetic trees were constructed
with the neighbor-joining algorithm,
by using bootstrap analysis with 500
replications for evaluation of the
matrices’ topology. Also, 1 region
with short sequence tandem repeats
(SSTR9) of F. tularensis was ampli-
fied as described previously (8).
Resulting products were subjected to
electrophoresis on a 3% MS-4
agarose gel (Pronadisa, Madrid,
Spain).
The 48 samples studied by serol-
ogy were negative. From the 26
human samples available for PCR, 1
was positive in the amplification of
Tul4, which represented a prevalence
rate of 3.8% of the samples studied.
This result was confirmed by repeat-
ing both the DNA extraction and the
PCR 3×. The amplification of SSTR9
in this case was negative. The differ-
ence between the results of the PCR
methods targeting Tul4 and SSTR9 in
the human sample is not surprising,
since Tul4 PCR has higher sensitivity
than that of SSTR9, which is a
method not optimal for direct use in
clinical samples (8,9). This positive
result was for a 43-year-old man, a
hunter who had frequent contact with
lagomorphs. At the time of the collec-
tion, he was asymptomatic, but a his-
tory of a recent febrile illness was
reported. He also stated that he had no
recent occupational or recreational
exposure in Spain. For the ticks, 1
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female D. reticulatus, collected from
a sheep, was positive in the amplifica-
tion of Tul4 and SSTR9, with a preva-
lence rate of 1.3% for D. reticulatus
and 0.9% considering the total of ticks
studied.
Sequence analyses of the 2 posi-
tive samples obtained (PoHuF1 and
PoTiF1 for human and tick, respec-
tively) showed a homology of 100%
with  F. tularensis. A phylogenetic
analysis based on the same sequence
also grouped the samples from tick
and human with F. tularensis subsp.
holarctica live vaccine strain
(Figure).
This study enabled the first report
of  F. tularensis DNA detection in
humans and ticks from Portugal.
When studying asymptomatic per-
sons, the likelihood of obtaining a
PCR-positive result in a sample from
a bacteremic patient would be expect-
ed to be much lower than finding a
seropositive result. However, we did
obtain a PCR-positive result from a
blood sample of a person, who, as
mentioned before, had a previous
tularemia-compatible febrile illness.
Indeed, in a previous study of 203
blood donors performed in the same
area during 2001–2002, a seropreva-
lence rate of 8.9% in asymptomatic
persons was found (10).
The low prevalence rates we
detected contribute to the assumption
that this disease should have a low
incidence in Portugal, as it does in
Spain. The results of this study repre-
sent the first direct evidence of F.
tularensis in Portugal. Further studies
to confirm the occurrence of human
cases are needed.
GenBank accession numbers for
the sequences generated in this study
are DQ459299 for PoHuF1,
DQ459300 for PoTiF1, and
DQ665890 for FT1.
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Figure. Neighbor-joining phylogenetic tree based on partial sequences of the gene coding
the 17-kDa lipoprotein of Francisella tularensis.